Patents Assigned to Ensemble Group Holdings
  • Methods of treating cancer in subjects having dysregulated lymphatic systems
    Patent number: 11104736
    Abstract: Provided herein is a method for treating cancer in a patient in need thereof, wherein said cancer has a tumor proportion score (TPS) for programmed death receptor-1 (PD-1) or programmed death-ligand-1 (PD-L1) of 50% or less and said patient is negative for lymphatic dysfunction, comprising administering a therapeutically effective amount of an antagonist for immune checkpoint inhibition.
    Type: Grant
    Filed: December 11, 2020
    Date of Patent: August 31, 2021
    Assignee: Ensemble Group Holdings
    Inventor: Michael David Kuo